Which stocks are gapping on Thursday?
By Mill Chart
Last update: Sep 22, 2022
Let's have a look at the gap up and gap down stocks in today's session.
Top Gap up stocks
| Ticker | Change | Comment |
|---|---|---|
| SPRO | 139.0% | SPERO THERAPEUTICS INC's (NASDAQ:SPRO) stock price is advancing with 139.0% to a price of $1.96 with a gap of 106.0%. The stock is trading 89.92% lower than 6 months ago. |
| OBLG | 16.61% | OBLONG INC's (NASDAQ:OBLG) stock price increased by 16.61% to $0.21 with a gap of 3.09%. The stock is trading 30.4% lower than a month ago. |
| AVCT | 13.91% | AMERICAN VIRTUAL CLOUD TECHN's (NASDAQ:AVCT) stock price increased by 13.91% to $0.25 with a gap of 9.89%. The stock is trading 53.27% higher than a month ago. |
| ALBO | 11.64% | ALBIREO PHARMA INC (NASDAQ:ALBO) rose 11.64% to $19.38 with a gap of 2.13% during Thursday's session. In the last 6 months the share price dropped with 42.15%. |
| COSM | 11.0% | COSMOS HOLDINGS INC (NASDAQ:COSM) rose 11.0% to $0.26 with a gap of 4.6% during Thursday's session. In the last month the share price dropped with 36.6%. |
| VIRT | 9.62% | VIRTU FINANCIAL INC-CLASS A's (NASDAQ:VIRT) stock price is advancing with 9.62% to a price of $23.47 with a gap of 4.41%. In the last 6 months the share price dropped with 42.4%. |
| SPRC | 6.67% | SCISPARC LTD's (NASDAQ:SPRC) shares rose 6.67% to $0.8 with a gap of 2.62%. The stock is trading 66.22% lower than 3 months ago. |
To see the full list of gap up stocks you can use our gap up stocks screener.
Gap down stocks
| Ticker | Change | Comment |
|---|---|---|
| TOPS | -21.43% | TOP SHIPS INC's (NASDAQ:TOPS) stock price decreased by 21.43% to $0.17 with a gap of 27.44%. Shareholders saw the stock price going 29.7% lower in the past month. |
| BCAN | -20.41% | BYND CANNASOFT ENTERPRISES's (NASDAQ:BCAN) shares fell 20.41% to $3.51 during Thursday's session with a gap of 36.63%. |
| PGYWW | -19.88% | PAGAYA TECHNOLOGIES LTD -27's (NASDAQ:PGYWW) stock price is declining with 19.88% to a price of $0.2 with a gap of 45.93%. In the last month the stock lost 65.75%. |
| AGRI | -12.99% | AGRIFORCE GROWING SYSTEMS LT's (NASDAQ:AGRI) shares fell 12.99% to $1.54 with a gap of 27.16%. The stock is trading 29.2% lower than 3 months ago. |
| HSDT | -12.94% | HELIUS MEDICAL TECHNOLOGIES's (NASDAQ:HSDT) shares fell 12.94% to $0.38 during Thursday's session with a gap of 18.72%. In the last month the stock lost 38.41%. |
| SXTC | -12.76% | CHINA SXT PHARMACEUTICALS IN's (NASDAQ:SXTC) shares fell 12.76% to $0.81 with a gap of 20.46%. In the last month the share price dropped with 38.0%. |
| CRH.W | -12.47% | COHN ROBBINS HOLDINGS -CW25's (NYSE:CRH.W) shares fell 12.47% to $0.35 with a gap of 30.0%. In the last 6 months the share price dropped with 48.71%. |
| LAZR | -12.22% | LUMINAR TECHNOLOGIES INC's (NASDAQ:LAZR) shares fell 12.22% to $8.22 during Thursday's session with a gap of 17.43%. In the last 3 months the share price increased with 25.1%. |
| VERO | -12.02% | VENUS CONCEPT INC's (NASDAQ:VERO) stock price decreased by 12.02% to $0.49 with a gap of 19.54%. Shareholders saw the stock price going 49.7% higher in the past month. |
| RMED | -11.8% | RA MEDICAL SYSTEMS INC's (NYSEARCA:RMED) stock price is declining with 11.8% to a price of $0.12 with a gap of 38.97%. A press release (Ra Medical Systems Announces Results of its Special Meeting of Stockholders and a 1-for-50 Reverse Stock Split) was released two days ago. |
For the full top loser list go to our gap down stocks screener.
SPERO THERAPEUTICS INC
NASDAQ:SPRO (4/19/2024, 7:17:18 PM)
After market: 1.4 0 (0%)1.4
-0.07 (-4.76%)
SPRO News
a month ago - InvestorPlaceToday’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on ThursdayIt's time to start the day with a breakdown of all the biggest pre-market stock movers worth watching on Thursday morning!
On track for topline data from SPR720 Phase 2a proof-of-concept trial in treatment-naive and treatment-experienced non-refractory NTM-PD patients, expected...
CAMBRIDGE, Mass., March 06, 2024 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutical company,...
CAMBRIDGE, Mass., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutical company,...
CAMBRIDGE, Mass., Feb. 26, 2024 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO) (Spero), a multi-asset clinical-stage biopharmaceutical...
CAMBRIDGE, Mass., Jan. 31, 2024 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutical company,...
In 2H 2024, expect to provide Phase 2a topline proof-of-concept data from our wholly-owned lead program SPR720 in NTM-PD patients
$95 million in development milestones payable over two years, as part of GSK license agreement...
6 months ago - Bragar Eagel & Squire, P.C.SPERO ALERT: Bragar Eagel & Squire, P.C. is Investigating Spero Therapeutics, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
